Literature DB >> 17037914

MALDI-MS direct tissue analysis of proteins: Improving signal sensitivity using organic treatments.

R Lemaire1, M Wisztorski, A Desmons, J C Tabet, R Day, M Salzet, I Fournier.   

Abstract

Direct tissue analysis using MALDI-MS allows the generation of profiles while maintaining the integrity of the tissue, displaying cellular localizations and avoiding tedious extraction and purification steps. However, lower spectral quality can result from direct tissue analysis due to variations in section thickness, the nature of the tissue, and the limited access to peptides/proteins due to high lipid content. To improve signal sensitivity, we have developed a tissue-washing procedure using organic solvents traditionally used for lipid extraction, i.e., CHCl3, hexane, toluene, acetone, and xylene. The increased detection for peptides/proteins (m/z 5000-30,000) is close to 40% with chloroform or xylene, and 25% with hexane, while also improving sample reproducibility for each solvent used in the present study. This strategy improved matrix cocrystallization with tissue peptides/proteins and more importantly with cytoplasmic proteins without delocalization. The extracted lipids were characterized by nanoESI-QqTOF/MS/MS using the precursor ion mode, lithium adducts, or both and were identified as phospholipids including phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and lysophosphatidylinositol, confirming membrane lipid extraction from the tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17037914     DOI: 10.1021/ac060565z

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  45 in total

1.  MALDI imaging and profiling MS of higher mass proteins from tissue.

Authors:  Alexandra van Remoortere; René J M van Zeijl; Nico van den Oever; Julien Franck; Rémi Longuespée; Maxence Wisztorski; Michel Salzet; André M Deelder; Isabelle Fournier; Liam A McDonnell
Journal:  J Am Soc Mass Spectrom       Date:  2010-08-04       Impact factor: 3.109

2.  From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Dale S Cornett; Peggi M Angel; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2010-08-23       Impact factor: 5.911

Review 3.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Revisiting rat spermatogenesis with MALDI imaging at 20-microm resolution.

Authors:  Mélanie Lagarrigue; Michael Becker; Régis Lavigne; Sören-Oliver Deininger; Axel Walch; Florence Aubry; Detlev Suckau; Charles Pineau
Journal:  Mol Cell Proteomics       Date:  2010-12-12       Impact factor: 5.911

Review 5.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

6.  Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry.

Authors:  M Lisa Manier; Michelle L Reyzer; Anne Goh; Veronique Dartois; Laura E Via; Clifton E Barry; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2011-05-13       Impact factor: 3.109

7.  Optimization of whole-body zebrafish sectioning methods for mass spectrometry imaging.

Authors:  Kimberly A Nelson; Gabrielle J Daniels; John W Fournie; Michael J Hemmer
Journal:  J Biomol Tech       Date:  2013-09

8.  The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.

Authors:  Rémi Longuespée; Charlotte Boyon; Céline Castellier; Amélie Jacquet; Annie Desmons; Olivier Kerdraon; Denis Vinatier; Isabelle Fournier; Robert Day; Michel Salzet
Journal:  Histochem Cell Biol       Date:  2012-04-25       Impact factor: 4.304

Review 9.  MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.

Authors:  Julien Franck; Karim Arafah; Mohamed Elayed; David Bonnel; Daniele Vergara; Amélie Jacquet; Denis Vinatier; Maxence Wisztorski; Robert Day; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2009-05-18       Impact factor: 5.911

10.  Imaging mass spectrometry: hype or hope?

Authors:  Ron M A Heeren; Donald F Smith; Jonathan Stauber; Basak Kükrer-Kaletas; Luke MacAleese
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-21       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.